Serine protease inhibitor A3 in atherosclerosis and aneurysm disease

Author：                              

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.30, Iss.2, 2012-01, pp. : 288-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm

By Sjöberg Sara  

Clinical Review in Bone and Mineral Metabolism, Vol. 9, Iss. 2, 2011-06 ,pp. : 138-147

Humana Press, Inc

Access to resources Recommend Favorite

A Novel Serine Protease Inhibitor Acts as an Immunomodulatory Switch while Maintaining Homeostasis

By  

Journal of Innate Immunity, Vol. 1, Iss. 5, 2009-03 ,pp. : 465-479

Karger

Access to resources Recommend Favorite

Mutations in the Serine Protease Inhibitor Kazal Type 1 (SPINK1) Gene in Japanese Patients with Pancreatitis

By  

Pancreatology, Vol. 5, Iss. 4-5, 2005-06 ,pp. : 354-360

Karger

Access to resources Recommend Favorite

Effect of Reoxygenation on the Hypoxia-Induced Up-Regulation of Serine Protease Inhibitor PAI-1 in Head and Neck Cancer Cells

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 282-291

Karger

Access to resources Recommend Favorite

The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B–dependent hepatotoxicity

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1530-1540

John Wiley & Sons Inc

Access to resources Recommend Favorite